Katalin Kariko's relentless advocacy for mRNA technology faced significant setbacks, including grant rejections and stalled career progression. Despite this, her perseverance paid off as her mRNA research played a crucial role in tackling the Covid-19 pandemic, ultimately earning her a Nobel Prize. Issues in scientific funding, including extensive delays and administrative burdens, hinder other innovative scientists. Current policy changes at N.I.H. threaten to exacerbate these challenges by limiting funding, raising concerns about the future of biomedical research and its ability to support pioneering work like Kariko's.
Katalin Kariko's persistent belief in mRNA technology, despite overwhelming skepticism, highlights how innovative science often struggles under a risk-averse funding system.
Kariko faced consistent rejection in her quest to harness mRNA for medicine, eventually leading to groundbreaking research that transformed disease treatment and her late Nobel Prize.
Collection
[
|
...
]